Successful Crizotinib Rechallenge after Crizotinib-Induced Organizing Pneumonia in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer

Crizotinib, a first-line anaplastic lymphoma kinase (ALK)-tyrosine kinase inhibitor, has shown promising results for the treatment of locally advanced and metastatic lung cancer presenting the ALK rearrangement. On the other hand, secondary organizing pneumonia (OP) caused by anti-cancer drugs has b...

Descripción completa

Detalles Bibliográficos

Autores principales:	Nobuhiro Asai, Toyoharu Yokoi, Etsuro Yamaguchi, Akihito Kubo
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Karger Publishers 2014-09-01
Colección:	Case Reports in Oncology
Materias:	Lung cancer Crizotinib Organizing pneumonia EML4-ALK
Acceso en línea:	http://www.karger.com/Article/FullText/366516
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!